Overexpression of p65 attenuates celecoxib-induced cell death in MDA-MB-231 human breast cancer cell line

BACKGROUND: Celecoxib is a selective cyclooxygenase (COX)-2 inhibitor that has been reported to reduce the risk of breast cancer. In our previous study, celecoxib induced apoptosis and caused cell cycle arrest at the G0/G1 phase in the breast cancer cell line MDA-MB-231, and its effects were mediate...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ling, Kang, Fubiao, Li, Jie, Zhang, Jing, Shan, Baoen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586361/
https://www.ncbi.nlm.nih.gov/pubmed/23402310
http://dx.doi.org/10.1186/1475-2867-13-14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586361/
https://www.ncbi.nlm.nih.gov/pubmed/23402310
http://dx.doi.org/10.1186/1475-2867-13-14

Ejemplares similares